{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:43:43Z","timestamp":1791053023942,"version":"4.1.0"},"reference-count":61,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2013,12,2]],"date-time":"2013-12-02T00:00:00Z","timestamp":1385942400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsia"],"published-print":{"date-parts":[[2014,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>The contribution of glial cells, mainly astrocytes and microglia, to the pathophysiology of epilepsy is increasingly appreciated. Glia play a pivotal role in the initiation and maintenance of the central nervous system (<jats:styled-content style=\"fixed-case\">CNS<\/jats:styled-content>) immune response and neuronal metabolic and trophic supply. Recent clinical and experimental evidence suggests a direct relationship between epileptic activity and<jats:styled-content style=\"fixed-case\">CNS<\/jats:styled-content>inflammation, which is characterized by accumulation, activation, and proliferation of microglia and astrocytes. Concomitant glia\u2010mediated mechanisms of action of several antiepileptic drugs (<jats:styled-content style=\"fixed-case\">AED<\/jats:styled-content>s) have been proposed. However, their direct effects on glial cells have been rarely investigated. We aimed to investigate the effect of commonly used<jats:styled-content style=\"fixed-case\">AED<\/jats:styled-content>s on glial viability, the gap junctional network, the microglial activation, and cytokine expression in an in vitro astroglia\/microglia co\u2010culture model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Primary astrocytic cultures were prepared from brains of postnatal (<jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>0\u2013<jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>2)<jats:styled-content style=\"fixed-case\">W<\/jats:styled-content>istar rats and co\u2010cultured with a physiologic amount of 5%, as well as 30% microglia in order to mimic inflammatory conditions. Co\u2010cultures were treated with valproic acid (<jats:styled-content style=\"fixed-case\">VPA<\/jats:styled-content>), carbamazepine (<jats:styled-content style=\"fixed-case\">CBZ<\/jats:styled-content>), phenytoin (<jats:styled-content style=\"fixed-case\">PHE<\/jats:styled-content>), and gabapentin (<jats:styled-content style=\"fixed-case\">GBT<\/jats:styled-content>). Viability and proliferation were measured using the tetrazolium (<jats:styled-content style=\"fixed-case\">MTT<\/jats:styled-content>) assay. The microglial activation state was determined by immunocytochemical labeling. The astroglial connexin 43 (<jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>x43) expression was measured by<jats:styled-content style=\"fixed-case\">W<\/jats:styled-content>estern blot analysis. The transforming growth factor\u2010\u03b21 (<jats:styled-content style=\"fixed-case\">TGF<\/jats:styled-content>\u2010\u03b21) and tumor necrosis factor\u2010\u03b1 (<jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>\u2010\u03b1) cytokine levels were measured by the quantitative sandwich enzyme immunosorbent assay (<jats:styled-content style=\"fixed-case\">ELISA<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Key Findings<\/jats:title><jats:p>Astrocytes, co\u2010cultured with 5% microglia (M5 co\u2010cultures), showed a dose\u2010dependent, significant reduction in glial viability after incubation with<jats:styled-content style=\"fixed-case\">PHE<\/jats:styled-content>and<jats:styled-content style=\"fixed-case\">CBZ<\/jats:styled-content>. Furthermore,<jats:styled-content style=\"fixed-case\">VPA<\/jats:styled-content>led to highly significant microglial activation at all doses examined. The antiinflammatory cytokine<jats:styled-content style=\"fixed-case\">TGF<\/jats:styled-content>\u2010\u03b21 release was induced by high doses of<jats:styled-content style=\"fixed-case\">GBT<\/jats:styled-content>and<jats:styled-content style=\"fixed-case\">PHE<\/jats:styled-content>.<\/jats:p><jats:p>Astrocytes co\u2010cultured with 30% microglia (M30 co\u2010cultures) revealed a dose\u2010dependent significant reduction in glial viability after incubation with<jats:styled-content style=\"fixed-case\">PHE<\/jats:styled-content>, accompanied by increased<jats:styled-content style=\"fixed-case\">TGF<\/jats:styled-content>\u2010\u03b21 and<jats:styled-content style=\"fixed-case\">TNF<\/jats:styled-content>\u2010\u03b1 levels. However,<jats:styled-content style=\"fixed-case\">CBZ<\/jats:styled-content>significantly reduced the amount of activated microglial cells and increased the total number of inactivated microglia. Finally,<jats:styled-content style=\"fixed-case\">CBZ<\/jats:styled-content>resulted in reduced viability at all doses examined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Significance<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">CNS<\/jats:styled-content>inflammation is characterized by a disturbance of glial cell functions. Strong microglial activation, a typical hallmark of inflammation, was induced by<jats:styled-content style=\"fixed-case\">VPA<\/jats:styled-content>in<jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>5 and continued in<jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>30 co\u2010cultures. With regard to the direct relation between<jats:styled-content style=\"fixed-case\">CNS<\/jats:styled-content>inflammation and seizures,<jats:styled-content style=\"fixed-case\">VPA<\/jats:styled-content>seems to be unsuitable for reducing inflammatory conditions. The reverse effect was achieved after<jats:styled-content style=\"fixed-case\">CBZ<\/jats:styled-content>. We noticed significant microglial inactivation, after incubation of the<jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>30 co\u2010cultures. In conclusion, we suggest that<jats:styled-content style=\"fixed-case\">AED<\/jats:styled-content>s with antiinflammatory glial features are beneficial for seizures caused by persistent brain inflammation.<\/jats:p><\/jats:sec>","DOI":"10.1111\/epi.12473","type":"journal-article","created":{"date-parts":[[2013,12,2]],"date-time":"2013-12-02T16:51:16Z","timestamp":1386003076000},"page":"184-192","source":"Crossref","is-referenced-by-count":86,"title":["Glia and epilepsy: Experimental investigation of antiepileptic drugs in an astroglia\/microglia co\u2010culture model of inflammation"],"prefix":"10.1111","volume":"55","author":[{"given":"Hannes","family":"Dambach","sequence":"first","affiliation":[{"name":"Department of Neuroanatomy and Molecular Brain Research Ruhr University Bochum Bochum Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hinkerohe","sequence":"additional","affiliation":[{"name":"Department of Neurology Ruhr\u2010University Bochum Knappschafts Hospital Bochum Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Prochnow","sequence":"additional","affiliation":[{"name":"Department of Neuroanatomy and Molecular Brain Research Ruhr University Bochum Bochum Germany"},{"name":"International Graduate School of Neuroscience (IGSN) Ruhr University Bochum Bochum Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin N.","family":"Stienen","sequence":"additional","affiliation":[{"name":"Department of Neuroanatomy and Molecular Brain Research Ruhr University Bochum Bochum Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Moinfar","sequence":"additional","affiliation":[{"name":"Department of Neuroanatomy and Molecular Brain Research Ruhr University Bochum Bochum Germany"},{"name":"International Graduate School of Neuroscience (IGSN) Ruhr University Bochum Bochum Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus G.","family":"Haase","sequence":"additional","affiliation":[{"name":"Department of Neurology Holy Spirit Hospital K\u00f6ln Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hufnagel","sequence":"additional","affiliation":[{"name":"Neuro\u2010Consil GmbH D\u00fcsseldorf Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro M.","family":"Faustmann","sequence":"additional","affiliation":[{"name":"Department of Neuroanatomy and Molecular Brain Research Ruhr University Bochum Bochum Germany"},{"name":"International Graduate School of Neuroscience (IGSN) Ruhr University Bochum Bochum Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,12,2]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2005.00298.x"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2011.09.033"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2011.03028.x"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100004388"},{"key":"e_1_2_6_6_1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1684\/epd.2007.0144","article-title":"Treatment of pediatric epilepsy: European expert opinion, 2007","volume":"9","author":"Wheless JW","year":"2007","journal-title":"Epileptic Disord"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2004.04.007"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1535-7597.2005.05101.x"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2011.03033.x"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(98)00024-2"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2008.49.1.1"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2010.178"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2011.10.011"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0969-9961(03)00127-X"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2007.10.002"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2010.02547.x"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.19-12-05054.1999"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2000.00140.x"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2004.07.023"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2005.01006.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2010.12.005"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1901-08.2008"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2010.06.004"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.190206797"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.01488.x"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2008.04.002"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1870"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.11-05-01421.1991"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(91)90128-M"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2042-07.2007"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0037-06.2006"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresrev.2009.10.004"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/glia.10141"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/glia.20223"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/glia.1106"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2010.03.012"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.01038.x"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.21639"},{"key":"e_1_2_6_39_1","first-page":"172","article-title":"[Serum concentration of anticonvulsants. Practical guidelines for measuring and useful interpretation. Therapy Committee of the German Section of the International Epilepsy League]","volume":"70","author":"Froscher W","year":"1999","journal-title":"Der Nervenarzt"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200302000-00009"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2006.00504.x"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.44.s10.5.x"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2234031100"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2003.08.001"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2009.05886.x"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2006.02.065"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2010.04.041"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2010.07.004"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2010.08.024"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/glia.20830"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(95)00516-1"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-010-1046-7"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.84980"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2010.07.014"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1016650108"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5247-10.2011"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3843(14)60080-3"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-7-62"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5949.2009.00115.x"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2013.05.010"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2013.01.011"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-007-9462-8"}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fepi.12473","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/epi.12473","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T20:49:56Z","timestamp":1716238196000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/epi.12473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,2]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["10.1111\/epi.12473"],"URL":"https:\/\/doi.org\/10.1111\/epi.12473","archive":["Portico"],"relation":{},"ISSN":["0013-9580","1528-1167"],"issn-type":[{"value":"0013-9580","type":"print"},{"value":"1528-1167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,2]]}}}